Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9ND2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,829
Award facts
- Contract value 100% obligated
- $17,828.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17.8K to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C (20 gram/200 mL vial) pharmaceutical product. The award was issued on January 27, 2026, with an ultimate completion date of February 18, 2026, and was structured as a firm fixed-price, non-set-aside contract. The work will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999.9M and running through December 2026, which serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through open competition on a full and open basis, demonstrating its capability to meet federal procurement requirements. The company, which is a subsidiary of Cencora, Inc., maintains a significant portfolio of federal contracts supplying critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the company's established position as a key vendor for federal medical procurement and its ability to efficiently fulfill government contracts for essential pharmaceutical products required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9ND2?
SPE2DR26F9ND2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F9ND2 worth?
The government has obligated $17,829 on SPE2DR26F9ND2.
Is contract SPE2DR26F9ND2 an order under another contract?
Yes. SPE2DR26F9ND2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9ND2 competed?
The extent of competition for SPE2DR26F9ND2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award